ZACHARY LOVELL: Open Payments
NPI 1336870641 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 13 payments from 8 companies in 2025. Trend: 2023 $987 · 2024 $969 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Novo Nordisk Inc | 2 | $40 |
| ABBVIE INC. | 1 | $21 |
| Eisai Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| bioMerieux Inc | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
Products named: AIRSUPRA, Ozempic, FARXIGA, VRAYLAR, Leqembi, CAPLYTA, BIOFIRE SPOTFIRE Control Station, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
